QualityStocksNewsBreaks Archives

WednesdayOct 21, 2026 9:20 am

QualityStocksNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Enters Counter-Drone Market With AI-Powered Wearable Detection Platform

Silynxcom (NYSE American: SYNX), a developer of advanced soldier-worn tactical communication solutions, announced its strategic entry into the counter-uncrewed aircraft systems ("C-UAS") market with the development of an artificial intelligence ("AI")-powered wearable drone detection and early-warning platform. Currently at the prototype stage, the standalone device is designed to identify drone acoustic signatures in real time, including threats from fiber-optic guided drones that conventional radio frequency-based systems may miss. The company is also developing mesh networking capabilities that would allow connected devices to share threat alerts across military units without relying on existing communications infrastructure. Silynxcom is establishing a dedicated counter-drone…

WednesdayOct 21, 2026 9:10 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF; FSE: Z58) Extends Confirmed Strike Length to Over 3.5 Kilometres at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF; FSE: Z58) announced that drill hole MM26-12 intersected 37.4 metres of the target Meade Peak Member, with oolitic zones characteristic of the Upper Phosphate Zone observed during core logging. Located approximately 200 metres southwest of MM26-11, the latest hole extends the confirmed strike length of the target zone to more than 3.5 kilometres. The company said assay results are pending to confirm the true thickness and phosphate content of the Upper Phosphatic Zone. CEO Robin Dow…

WednesdayOct 21, 2026 9:00 am

QualityStocksNewsBreaks – JPMorgan Chase & Co. (NYSE: JPM) Expands JPM Coin to Ethereum for Institutional Payments and Asset Settlement

JPMorgan Chase (NYSE: JPM) has technically deployed its JPM Coin deposit token on the Ethereum mainnet, enabling eligible institutional clients to transfer funds within seconds, around the clock. According to an Oct. 19 report by Ezra Reguerra and Yohan Yun of Cointelegraph, the token represents U.S. dollar deposits held at JPMorgan. Emma Landriault, global head of Kinexys Labs, said crypto companies could use the token for blockchain payments, while financial institutions could use it to settle trades and post collateral. Landriault said Ethereum was selected for its liquidity and existing use among clients, while JPM Coin transactions will remain restricted…

TuesdayOct 20, 2026 3:43 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Unveils SSi Mantra 3.0 at Kings Hospital Colombo

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, is expanding its international footprint with the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva, and the hospital reportedly completed more than 25 robotic procedures within the first three weeks. The launch adds to SS Innovations’ international expansion as the company reported 224 cumulative SSi Mantra installations…

TuesdayOct 20, 2026 3:14 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Scales GelrinC Manufacturing Amidst Development Progress

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel technology, designed to promote the regeneration of durable, natural-like cartilage in patients with painful knee cartilage injuries. The cell-free, off-the-shelf implant temporarily fills cartilage defects before gradually resorbing as surrounding tissue regenerates. Long-term MRI findings and peer-reviewed Phase II clinical data have provided evidence of cartilage maturation and durable structural repair, while the company has reported greater pain improvement than traditional microfracture. Regentis has treated 43 of 80 planned patients in its U.S. pivotal Phase III trial, with enrollment expected to conclude around the end of 2026, and is preparing for…

TuesdayOct 20, 2026 11:48 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Targets $3 Million in Additional Annualized Operating Expense Reductions

Beeline Holdings (NASDAQ: BLNE), a digital mortgage and home equity platform, announced an additional operating expense reduction plan targeting approximately $250,000 in monthly savings, or $3 million annually, beyond cost reductions implemented earlier in 2026. The initiative includes workforce reductions, infrastructure consolidation and elimination of legacy overhead costs, with approximately $270,000 in one-time transition expenses expected through Dec. 1, 2026. The company anticipates realizing the full monthly savings thereafter, supporting its efforts to improve operating leverage and accelerate its path toward positive operating cash flow. Beeline continues to leverage its MagicBlocks AI customer acquisition technology and new mortgage pricing engine…

TuesdayOct 20, 2026 11:37 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Completes 1-for-150 Reverse Stock Split to Support Nasdaq Uplisting

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the completion of a 1-for-150 reverse stock split effective Oct. 20, 2026, reducing its outstanding common shares from approximately 543.9 million to 3.6 million. The company's shares began trading on a split-adjusted basis under the temporary symbol NGTFD on Oct. 20 and will revert to NGTF after 20 trading days. The reverse split applies proportionately to all shareholders, with fractional shares rounded up to the next whole share, and does not change the number of authorized shares. The reverse split is intended to increase the per-share trading price and support…

TuesdayOct 20, 2026 11:20 am

QualityStocksNewsBreaks – TruGolf Holdings, Inc. (NASDAQ: TRUG) Featured in AINewsWire Editorial Highlighting Expansion Into Regulated Asset Tokenization

TruGolf (NASDAQ: TRUG) was featured in an AINewsWire editorial examining the growing institutional adoption of blockchain technology and the importance of regulatory compliance in tokenized asset markets. The editorial highlights TruGolf's acquisition of Polymath Research Inc. and its Polymesh Layer-1 blockchain, which provides infrastructure for regulated digital securities. Polymath reported more than $132 million in tokenized assets issued on its platform by year-end 2025, with more than 65 active issuers and over 50 ecosystem partners. The editorial also discusses plans to deploy the technology within TruGolf Links Franchising through tokenized equipment leasing and fractional ownership opportunities, along with Polymath's exploration…

TuesdayOct 20, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline

VERAXA is implementing FDA-aligned New Approach Methodologies (“NAMs”) across its preclinical research programs, aiming to improve the relevance of experimental findings to human biology while reducing animal testing. The strategy supports development of the company’s BiTAC(R) T-cell engagers, BiTAC-based antibody-drug conjugates and bispecific antibody-drug conjugates for the treatment of cancer. New three-dimensional spheroid data reportedly reinforce the ability of VERAXA’s models to assess the dual-target specificity of its lead T-cell engager candidates. An ex vivo study involving 10 low-passage patient-derived xenograft models of non-small cell lung cancer required about 10 mice, compared with an estimated 200 or more for comparable…

TuesdayOct 20, 2026 9:00 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present AI-Enabled Drug Discovery Keynote at 22nd Drug Discovery Strategic Summit

Oncotelic Therapeutics (OTCQB: OTLC) announced that Chief Business Officer Saran Saund will deliver the opening keynote on the second day of the 22nd Drug Discovery Strategic Summit on Oct. 22, 2026, at 9 a.m. Pacific Time in Millbrae, California. The presentation will explore partition and aggregation as an organizing principle for AI-enabled drug discovery, emphasizing how complex research questions can be divided into focused investigations and findings combined to develop testable hypotheses. Saund will discuss the company's proprietary PDAOAI platform, which indexes approximately 29 million PubMed abstracts, along with its international intellectual property strategy, planned expansion into genetic discovery and…

Site Search

Company Search

Category: QualityStocksNewsBreaks